Effect of treatment with rhGM-CSF and low-dose cytosine arabinoside on leukemic blast cells in patients with myelodysplastic syndromes

Haematol Blood Transfus. 1990:33:763-9. doi: 10.1007/978-3-642-74643-7_138.

Authors

D Hoelzer¹, A Ganser, O G Ottmann, K Höffken, R Becher, D Lutz, O Krieger, V Diehl, B Lathan, M A Boogaerts, et al.

Affiliation

¹ Dept. of Hematology, University of Frankfurt, FRG.

PMID: 2182466
DOI: 10.1007/978-3-642-74643-7_138

No abstract available

MeSH terms

Adult
Aged
Cell Differentiation / drug effects
Cell Division / drug effects
Colony-Stimulating Factors / pharmacology
Colony-Stimulating Factors / therapeutic use*
Combined Modality Therapy
Cytarabine / therapeutic use*
Drug Evaluation
Drug Synergism
Granulocyte-Macrophage Colony-Stimulating Factor
Growth Substances / pharmacology
Growth Substances / therapeutic use*
Hematopoiesis / drug effects
Humans
Leukocyte Count
Middle Aged
Myelodysplastic Syndromes / drug therapy
Myelodysplastic Syndromes / therapy*
Neoplastic Stem Cells / drug effects
Recombinant Proteins / therapeutic use

Substances

Colony-Stimulating Factors
Growth Substances
Recombinant Proteins
Cytarabine
Granulocyte-Macrophage Colony-Stimulating Factor